Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109909 · ClinicalTrials.gov registry record · NA
Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury
A NA study of Mild Traumatic Brain Injury and Photophobia, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06109909: Recruiting NA study of Mild Traumatic Brain Injury and Photophobia, sponsored by VA Office of Research and Development.
NCT06109909 is a NA study of Mild Traumatic Brain Injury and Photophobia that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 36 participants, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06109909, a NA study of Mild Traumatic Brain Injury and Photophobia, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to complete a pilot study testing the feasibility and acceptability of low-intensity pulse-based transcranial stimulation (LIP-tES) neurofeedback intervention for reducing photosensitivity symptoms in Veterans with a history of mild traumatic brain injury (mTBI). The study will also complete resting-state MRI scans to assess neurophysiological markers of photosensitivity and changes associated with LIP-tES intervention.
Primary Outcome
The UPSIS questionnaire is a 17-item questionnaire designed to quantitatively assess photosensitivity symptoms and their impact on activities of daily living. Scores range from 0-80 with higher values indicating more severe photosensitivity symptoms.
Conditions Studied
Interventions
- DEVICE Micro Current Neurofeedback Device using Low-Frequency Pulse-Based Transcranial Electrical Stimulation
Study Locations (1)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What NCT06109909 shows while recruiting
NCT06109909 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Micro Current Neurofeedback Device using Low-Frequency Pulse-Based Transcranial Electrical Stimulation is the first listed.
NCT06109909 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06109909 about?
NCT06109909 is a clinical study titled "Pilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury". The goal of this study is to complete a pilot study testing the feasibility and acceptability of low-intensity pulse-based transcranial stimulation (LIP-tES) neurofeedback intervention for reducing photosensitivity symptoms in Veterans with a history of mild traumatic brain injury (mTBI). The study ...
What is the current status of trial NCT06109909?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-01-01. Estimated completion is 2026-11-30.
What conditions does trial NCT06109909 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Photophobia.
What interventions are being tested in trial NCT06109909?
The interventions under investigation include: Micro Current Neurofeedback Device using Low-Frequency Pulse-Based Transcranial Electrical Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06109909?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06109909 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06109909's enrollment target sits among peer trials
36 36th of 43 higher than 7 of 43 other Mild Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
-
Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
RECRUITING · NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI